Skip to content

Study on Traditional Chinese Medicine Intervention Program for the Sequela of novel coronavirus pneumonia (COVID-19)

Study on traditional Chinese Medicine intervention Program of COVID-19 's convalescence and sequelae based on COVID-19 case Registration system

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038740
Enrollment
Unknown
Registered
2020-09-30
Start date
2020-08-01
Completion date
Unknown
Last updated
2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Jiexingjunzi granule group:Jiexingjunzi granules
Qibei Fuzheng granule formation:Qibei Fuzheng granule

Sponsors

Beijing University of Chinese Medicine Third Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who meet the recovery period of new coronavirus pneumonia; 2. Syndrome differentiation is of Qi and Yin deficiency type; 3. Informed consent to this study, voluntarily participate in clinical research; 4. Can provide detailed contact information, have no short-term relocation wishes, and are willing to cooperate with follow-up.

Exclusion criteria

Exclusion criteria: 1. Patients with fasting water due to gastrointestinal bleeding, intestinal obstruction, etc.; 2. Those who cannot cooperate with the original severe brain, heart, liver, kidney and hematopoietic system diseases; those with malignant tumors and mental and neurological disorders who cannot cooperate; 3. People with allergies or allergic to the components of the research drug; 4. People with abnormal liver function and abnormal kidney function.

Design outcomes

Secondary

MeasureTime frame
Summary of the World Health Organization quality of Life scale;Score of main symptoms and signs;Pulmonary function;Chest CT examination;

Primary

MeasureTime frame
TCM syndrome score;

Countries

China

Contacts

Public ContactChengxiang Wang

Beijing University of Chinese Medicine Third Affiliated Hospital

wang601@vip.sina.com+86 18612922358

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026